Silodosin
- Generic Name
- Silodosin
- Brand Names
- Rapaflo, Silodyx, Urorec, Silodosin Recordati
- Drug Type
- Small Molecule
- Chemical Formula
- C25H32F3N3O4
- CAS Number
- 160970-54-7
- Unique Ingredient Identifier
- CUZ39LUY82
- Background
Silodosin is a selective antagonist of alpha(α)-1 adrenergic receptors that binds to the α subtype with the highest affinity. α1-adrenergic receptors regulate smooth muscle tone in the bladder neck, prostate, and prostatic urethra: the α subtype accounts for approximately 75% of α1-adrenoceptors in the prostate.
...
- Indication
Silodosin is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). It is not indicated for the treatment of hypertension.
- Associated Conditions
- Benign Prostatic Hyperplasia (BPH)
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath